Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy.
N Shahrizaila, Y Noto, N G Simon...
https://pubmed.ncbi.nlm.nih.gov/27940147Actively Recruiting
Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2026-03-10
39
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating nerve function and structure in patients with Charcot-Marie-Tooth disease (CMT) and certain acquired neuropathies, including chronic inflammatory demyelinating polyneuropathy (CIDP) and anti-MAG neuropathy. The study aims to compare conventional nerve conduction studies and axonal excitability assessments using the TRONDF protocol, along with analyzing nerve fibers from skin biopsies and performing ultrasound evaluations of nerves and intrinsic hand muscles. This research hopes to better distinguish different neuropathy types and understand disease mechanisms. The study involves several assessments: conventional nerve conduction tests, axonal excitability techniques delivering electrical stimuli to nerves, skin biopsies in some patients to examine myelinated nerve fibers, and ultrasound imaging of nerves and hand muscles. These methods are used to analyze nerve function, structure, and muscle characteristics. The study includes patients with various types of CMT and compares them to patients with CIDP and anti-MAG neuropathy, as well as corresponding mouse models. Participants will undergo nerve conduction and excitability tests, skin biopsies if applicable, and ultrasound scans over a two-year period. Researchers will measure nerve excitability parameters such as strength-duration time constant, recovery cycle, threshold electrotonus, and current-threshold relationship. Ultrasound will assess peripheral nerve size, muscle thickness, and echogenicity. The study will correlate these measurements with clinical and electrophysiological data to improve diagnosis and monitoring of these neuropathies.
CONDITIONS
Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 years
Participants undergo nerve and muscle ultrasounds and neurophysiological tests to assess nerve function and structure related to Charcot-Marie-Tooth disease and other neuropathies.
Periodic visits over 2 years
Duration - Up to 2 years
Participants are monitored to track disease progression and correlate ultrasound and neurophysiological findings with clinical outcomes.
Follow-up visits during the 2-year observation period
Total: 1 location
1
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, Italy, 20133
Actively Recruiting
D
Davide Pareyson, MD
A
Amedeo De Grado, M.D.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
N Shahrizaila, Y Noto, N G Simon...
https://pubmed.ncbi.nlm.nih.gov/27940147L Padua, G Granata, M Sabatelli...
https://pubmed.ncbi.nlm.nih.gov/24099922Yu-ichi Noto, Kensuke Shiga, Yukiko Tsuji...
https://pubmed.ncbi.nlm.nih.gov/25091364Stefanie Schreiber, Andreas Oldag, Cornelia Kornblum...
https://pubmed.ncbi.nlm.nih.gov/23381770Fiore Manganelli, Maria Nolano, Chiara Pisciotta...
https://pubmed.ncbi.nlm.nih.gov/26362287Lucilla Nobbio, Davide Visigalli, Davide Radice...
https://pubmed.ncbi.nlm.nih.gov/24812204D Burke, M C Kiernan, H Bostock
https://pubmed.ncbi.nlm.nih.gov/11514239M C Kiernan, D Burke, K V Andersen...
https://pubmed.ncbi.nlm.nih.gov/10679717H Bostock, K Cikurel, D Burke
https://pubmed.ncbi.nlm.nih.gov/9466589Mihai Moldovan, Susana Alvarez, Volodymyr Pinchenko...
https://pubmed.ncbi.nlm.nih.gov/21169333